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Weakening link to
colorectal cancer?
The catalytic -subunit of the enzymephosphatidylinositol-3-OH kinase(PI(3)K) relays signals from G-
protein-coupled receptors at the cell mem-
brane and mediates leukocyte responses to
chemokines and chemoattractants1–3. Sasaki
et al.4 report that mice that cannot produce
PI(3)K have a high incidence of colorectal
carcinomas, causing weight loss and prema-
ture death. However, PI(3)K-null mouse
strains have been independently generated in
three other laboratories; none of these mice
developed tumours and their weight and
lifespan were normal. This casts coubt on the
idea that loss of functional PI(3)K leads
directly to transformation of colon epithelial
cells and tumour progression.
Disrupting signalling by chemokine
receptors has been considered as a strategy
to fight chronic inflammatory disease. 
Signals from these receptors are integrated
by PI(3)K5,6, whose crystal structure7 and
inhibitor interactions8 are understood in
detail, paving the way to rapid therapeutic
exploitation of PI(3)K as a drug target.
But promising research was interrupted by
the claim of Sasaki et al.4 that loss of func-
tional PI(3)K causes colon cancer in mice. 
Sasaki et al.4 base their conclusions on
the fact that their PI(3)K-null mouse strain
rapidly developed colorectal carcinomas.
Using total colon and mucosal samples, they
detected PI(3)K in colon tissue but not in
murine or human colorectal adenocarcino-
mas, inferring that the loss of PI(3)K was
crucial to the transformation process in
epithelial cells.
The murine PI(3)K gene was indepen-
dently inactivated by four groups, including
ourselves1–3 and B.L. et al. (unpublished
observations), using four different strategies
(Fig. 1a), all of which confirmed that this
enzyme is important for transmission of
inflammatory signals. In our studies, how-
ever, mice lacking PI(3)K did not develop
tumours, or succumb to weight loss and 
premature death (Fig. 1b). Analysis of tissue
biopsies from more than 100 PI(3)K-null
mice at various ages and of both sexes from
two genetic backgrounds (129/Sv inbred and
C57BL/6J/129 outbred) showed no malig-
nant transformation (results not shown). 
We therefore re-examined the PI(3)K-
expression pattern reported by Sasaki et al.4,
and found that PI(3)K signals in colonic
mucosa correlate with the presence of leuko-
cytes, as shown by the CD18 marker or by
histology, but that PI(3)K is undetectable
in normal colonic epithelial cells (positive
for the Lu5 cytokeratin marker) from mice,
human patients or rats (Fig. 1c–e). We con-
clude that normal and transformed colonic
epithelial cells (such as the HT29 cancer cell
line) do not express detectable amounts of
PI(3)K, making a direct cause-and-effect
relationship between loss of PI(3)K and
development of colon cancer unlikely.
Invasiveness and growth-factor-in-
dependent survival of human colorectal
HCT8/S11 tumour cells was promoted by
constitutively active, membrane-targeted
PI(3)K (PI(3)K–CAAX), but not by its
absence or by stable transfection with cat-
alytically inactive PI(3)K (KR–CAAX; Fig.
1f). This suggests that malignancy is cou-
pled to activated PI(3)K and not to its loss.
Our findings are consistent with a lack
of tumorigenesis in PI(3)K-null strains
generated by three out of four strategies.
The reproducibility and consistency of the
diverging results, however, make it possible
that an unknown gene-targeting effect
enhances other growth-promoting signals in
the PI(3)K-null allele used by Sasaki et al.4.
Their interesting phenotype therefore needs
further investigation, and may eventually
reveal an important cause of colon cancer.
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Figure 1 Gene targeting and expression of phosphatidylinositol-3-OH kinase -subunit (PI(3)K). a, The wild-type PI(3)K allele (WT) was
targeted using four strategies. Allele I: interception1 of exon 2 (embryonic stem cells and mouse strains indicated; for details of the PI(3)K
gene, see ref. 9); allele II: deletion of exon 2, as carried out by Sasaki et al.2,4; direction of transcription of Neo is opposite to that of PI(3)K;
allele III: fusion3 of PI(3)K to green fluorescent protein (GFP) and excision of exon 2; allele IV: start of exon 2 deleted (~350 base pairs; B.L.
et al., unpublished observations). b, Weight and mortality of normal (filled symbols; black lines) and PI(3)K/ (allele I: white symbols; blue
lines) mice; 465 WT and 602 PI(3)K/ animals; age, 2 yr; sex ratio, 9/10 WT and 34/8 PI(3)K/ females/males; mortality from 
Sasaki et al.4 shown in red). c, Murine WT (+) and PI(3)K/ () splenocytes (spl.), total colon, mechanically sheared mucosa and 
isolated colon epithelial cells were probed for the leukocyte marker CD18, PI(3)K (mouse monoclonal anti-PI(3)K, amino-terminal 
epitope), and the pan-epithelial marker Lu-5. d, Anti-PI(3)K and Lu-5 western blots of total human cell lysates from neutrophils (NØ),
retinoic-acid-differentiated HL60, primary cultures of normal human colonocytes10 from large bowel resected from four patients with diverti-
culitis, and the HT29-Cl.16E cell line. e, PI(3)K immunoreactivity (red) in rat colonic mucosa (inset, cross-section of crypt). f, Invasion of
collagen gels and serum-withdrawal-induced apoptosis of human colorectal HCT8/S11 cells stably transfected with control vector (C),
membrane-targeted PI(3)K (PI(3)K–CAAX, black bars11) or a catalytically inactive mutant (PI(3)K(K833R)–CAAX; KR–CAAX, white bars).
The PI(3)K inhibitor LY294002 (LY) was used at 10 M. Further details are available at http://www.unifr.ch/biochem/wymann.
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